Precipio (PRPO) Stock: Buy, Sell, or Hold?
PRPO - Precipio, Inc. Common Stock
$22.73
-0.95 (-4.01%)
▼
5d:
-7.11%
30d:
-18.13%
90d:
-10.02%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When PRPO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PRPO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PRPO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PRPO is currently trading at $22.73, which is considered oversold relative to its 30-day fair value range of $24.51 to $28.85.
Technical Outlook: Technically, PRPO is in a uptrend. The price is currently testing key support at $22.45. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: PRPO scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRPO is in a uptrend. The price is currently testing key support at $22.45. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: PRPO scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$24.51 -
$28.85
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BEARISH: Trading 16.4% above Wall St target ($19.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$24.51 -
$28.85
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$22.45
Resistance Level
$27.04
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.43
Wall Street Target
$19.00
(-16.4%)
Revenue Growth (YoY)
24.2%
Profit Margin
-4.5%
Share & Embed Analysis
Last updated: October 02, 2026 3:32 AM ET
Data refreshes hourly during market hours. Next update: 4:32 AM
Data refreshes hourly during market hours. Next update: 4:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRPO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 43 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 48 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 46 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$345 | 65 BUY |
